Hopen is interested in a variety of promising early- to mid-stage life science product
ideas – pharmaceuticals, devices, and other technologies. Our partnership process varies
depending on the nature of the product, but an inventor/IP owner can generally expect the
following from a relationship with Hopen:
- We take a thorough, practical approach to investment selection and execution,
reviewing all ideas/proposals submitted.
- Once past the initial screening, we enter a due diligence process, which may be
followed by a contractual agreement. A typical agreement would preserve a significant
equity position for the scientific inventor.
- Drawing from our resource network, we form a specialized team to accelerate product
development. The focus is on building product value through efficiency.
- As development progresses, we form strategic alliances with outside partners to
bring the product to market. Several business options are considered, including joint
venture, outright sale, etc.
- Hopen remains involved with the scientific inventor throughout all stages of the
process, working to facilitate rapid product development and value creation.
|
Hopen Therapeutics supports its portfolio investments by providing:
- Strategic guidance – Hopen’s leadership team stays actively involved by setting the
focus and vision, tracking progress to goals, and advising on high-level issues. We also carefully
manage business alliances and work to help inventors realize their vision.
- Managerial support – Our staff can take the lead in project management by establishing work
plans, budgets, and milestones; forming efficient project teams; handling regulatory file submission
and marketing authorizations; managing intellectual property issues; and creating effective lifecycle
management strategies.
- Financial support – Hopen assumes the financial risk for its invested companies/projects,
providing full funding for the duration of the development process. We commit for longer periods of time
than strict venture capitalists, because we’re interested in commercial success.
- Product pipeline expertise – Hopen oversees the product development process and negotiates
effective agreements with individuals and institutions offering scientific, regulatory, clinical, and
market development expertise.
If you have a promising life science idea and are in need of financial/strategic assistance, you are
invited to contact Hopen.
|
To ensure a successful fit between our capabilities and a potential investment, Hopen evaluates
opportunities using several criteria. Some of our best avenues to building value in the pharmaceutical
arena include:
- Compelling target – Candidates must be in the life science field and hold significant
promise, but the therapeutic focus is open.
- Known lead compound – In the pharmaceutical field, ideal candidates are often focused on
orphan drug compounds and institutionally sponsored compounds.
- Identified therapeutic market – Ideal candidates offer a strong market potential and clear
freedom to operate in developed markets (including NDA/ANDA).
- Positive animal study results – In the pharmaceutical market, ideal candidates are in the
pre-clinical to early clinical development stage, allowing us to put our resource network to work in
the development gap.
|
|
|
|